Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Professional Market Insights, Players, Region, Type & Application Analysis 2018-2029

Report ID: ARS3571 | Category: Healthcare and Pharmaceuticals | Pages: 124 | Format: PDF | Published Date: September 07,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$4680.00 Multi User-$7900.00

Report Description
View Table of Contents

Report Summary

The global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market size in 2022 is 20590.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 5.40% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market include Assertio Holdings, Inc., Bayer AG, Amgen Inc, Lion Corporation, and Dr. Reddy’s Laboratories Ltd.. The share of the top 3 players in the Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Arthritis accounted for XX% of Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market in 2022. Migraine share of XX%.
Oral accounted for XX% of the Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market in 2022. Parenteral accounts for XX%.

The cumulative impact of COVID-19, Russia-Ukraine conflict, and high inflation is expected to have a significant long-term impact on the global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) markets. Ongoing research considers changes in consumer behavior, supply chain disruptions, and government intervention caused by the pandemic. Likewise, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine conflict and its potential impact on the supply-demand balance, pressure on pricing variables, and import, export, and trade. In addition, the report discusses the impact of high inflation on the global economy and details fiscal policies to measure and reduce its impact on demand, supply, cash flows, and currency exchange.

Market Statistics:
Reports provide market sizes and forecasts for multiple major currencies (USD, EUR, JPY, GBP, CNY, etc.); multi-currency support helps organizational leaders make informed decisions. This report takes 2018-2021 as the historical year, 2022 as the base year, 2023 as the semi-forecast year, and 2024-2029 as the full forecast year.

Market Share Analysis:
Market share analysis provides deep insights into the current status of vendors in a particular market space. By comparing suppliers' contributions to total revenue, customer base, and other key metrics, we can give companies a better understanding of their performance and the challenges they face as they compete for market share. The analysis also sheds light on the competitiveness of any given sector in terms of accumulation, diversification of strengths, and consolidation characteristics during the base year studied.

The report provides insights on the following metrics:
Market Penetration: Provides comprehensive information on the market offered by key players
Market Diversification: Provides detailed information on new product launches, greenfield regions, recent developments and investments
Market Trends: A Big Picture of the Cumulative Impact of COVID-19, Russia-Ukraine Conflict, and High Inflation
Competitive assessment and intelligence: Provides an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape and manufacturing capabilities of leading players
Product Development & Innovation: Provides intelligent insights into future technologies, R&D activities, and breakthrough product developments
Market Segmentation: Segment by Type, Application, and Region to provide detailed insights into market information.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America
Europe
China
Japan
Korea
Southeast Asia
India
South America
Middle East & Africa

Player list
Assertio Holdings, Inc.
Bayer AG
Amgen Inc
Lion Corporation
Dr. Reddy’s Laboratories Ltd.
Novartis AG

Types list
Arthritis
Migraine
Ophthalmic Diseases
Others

Application list
Oral
Parenteral

Table of Content

1 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Introduction and Overview
1.1 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Manufacturer
2.2 Manufacturers Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Production Sites, Area Served, Product Types
2.3 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Competitive Situation and Trends
2.3.1 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Assertio Holdings, Inc.
3.1.1 Assertio Holdings, Inc. Company Profile
3.1.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.1.3 Assertio Holdings, Inc. Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2018-2023)
3.1.4 Assertio Holdings, Inc. Business Overview
3.2 Bayer AG
3.2.1 Bayer AG Company Profile
3.2.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.2.3 Bayer AG Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2018-2023)
3.2.4 Bayer AG Business Overview
3.3 Amgen Inc
3.3.1 Amgen Inc Company Profile
3.3.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.3.3 Amgen Inc Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2018-2023)
3.3.4 Amgen Inc Business Overview
3.4 Lion Corporation
3.4.1 Lion Corporation Company Profile
3.4.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.4.3 Lion Corporation Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2018-2023)
3.4.4 Lion Corporation Business Overview
3.5 Dr. Reddy’s Laboratories Ltd.
3.5.1 Dr. Reddy’s Laboratories Ltd. Company Profile
3.5.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.5.3 Dr. Reddy’s Laboratories Ltd. Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2018-2023)
3.5.4 Dr. Reddy’s Laboratories Ltd. Business Overview
3.6 Novartis AG
3.6.1 Novartis AG Company Profile
3.6.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.6.3 Novartis AG Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2018-2023)
3.6.4 Novartis AG Business Overview
4 Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Historical and Forecast Market Analysis by Type
4.1 Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type
4.2 Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast by Type (2023-2029)
5 Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Historical and Forecast Market Analysis by Application
5.1 Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2018-2023)
5.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast by Application (2023-2029)
6 Global Market Growth Trends Analysis
6.1 Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast (2018-2029)
6.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends Analysis by Regions
6.2.1 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2018 VS 2023 VS 2029
6.2.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Revenue Market Size by Regions (2018-2023)
6.2.3 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Revenue Market Size by Regions (2023-2029)
6.2.4 North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast (2018-2029)
6.2.5 Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast (2018-2029)
6.2.6 China Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast (2018-2029)
6.2.7 Japan Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast (2018-2029)
6.2.8 Korea Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast (2018-2029)
6.2.9 Southeast Asia Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast (2018-2029)
6.2.10 India Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast (2018-2029)
6.2.11 South America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast (2018-2029)
6.2.12 Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast (2018-2029)
7 North America
7.1 North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players
7.2 North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Types
7.3 North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Applications
7.4 North America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2018-2023)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players
8.2 Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Types
8.3 Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Applications
8.4 Europe Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2018-2023)
8.5 Europe PEST Analysis
9 China
9.1 China Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players
9.2 China Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Types
9.3 China Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Applications
9.4 China Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2018-2023)
9.5 China PEST Analysis
10 Japan
10.1 Japan Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players
10.2 Japan Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Types
10.3 Japan Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Applications
10.4 Japan Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2018-2023)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players
11.2 Korea Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Types
11.3 Korea Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Applications
11.4 Korea Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2018-2023)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players
12.2 Southeast Asia Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Types
12.3 Southeast Asia Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Applications
12.4 Southeast Asia Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2018-2023)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players
13.2 India Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Types
13.3 India Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Applications
13.4 India Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2018-2023)
13.5 India PEST Analysis
14 South America
14.1 South America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players
14.2 South America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Types
14.3 South America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Applications
14.4 South America Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2018-2023)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players
15.2 Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Types
15.3 Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Applications
15.4 Middle East & Africa Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross and Gross Margin (2018-2023)
15.5 Middle East & Africa PEST Analysis
16 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Industrial Chain Analysis
17 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Dynamic Analysis
17.1 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends Analysis
17.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers Analysis
17.3 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges Analysis
17.4 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints Analysis
18 Research Findings and Conclusion

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Professional Market Insights, Players, Region, Type & Application Analysis 2018-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?